Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

NuvaRing trial date set in New Jersey mass tort

Filed April 10th, 2012 Laurie

The judge overseeing the NuvaRing mass tort lawsuit has set a date for the first bellwether trial.

According to a report at AboutLawsuits.com, Judge Brian Martinotti ruled last week that Feb. 4, 2013, will be the expected start of the first case involving a plaintiff claiming the NuvaRing contraception device caused serious and life-threatening blood clots.

Martinotti is presiding over a mass tort lawsuit filed in a Bergen County, N.J., state courtroom. The judge has not decided which of the nine cases selected out of a larger group of lawsuits will be tried first but that all will be ready for trial at that time. In addition to these 9 cases, there are at least another 125 similar lawsuits filed in New Jersey state courts. More than 800 NuvaRing lawsuits have been filed in federal courts across the country. Those lawsuits have been consolidated as part of Multidistrict Litigation in U.S. District Court for the Eastern District of Missouri.

Each filed lawsuit claims the makers of NuvaRing, Merck, has not disclosed the potential dangers of its self-implanted contraception device, especially its link to life-threatening blood clots, deep vein thrombosis, pulmonary embolism, heart attack, and stroke. Women who were prescribed NuvaRing often claim they were sold on the convenience of the device and it being a new treatment.

NuvaRing uses a combination of ethinyl estradiol, a form of estrogen, and etonogestral. Most hormonal forms of contraception have proven to carry some degree of dangerous side effects to the women taking them.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!